Corrections Issued for Colibactin-Driven Colon Cancer Study; Shingles Vaccine Gains Attention as Potential Anti-Aging Tool
Recent news highlights corrections to a study on colibactin-driven colon cancer, while separate reports suggest a common vaccine may have unexpected anti-aging benefits. A study published in Nature on November 6, 2024, investigating the relationship between cancer, the microenvironment, colon cancer, DNA damage response, experimental disease models, and pathogens, required corrections to labels in Figures 2 and 3. The errors involved the labels fimH and fmlH, which have been updated in the HTML and PDF versions of the article, according to Nature News. The research involved affiliations across several Belgian institutions.
Separately, the shingles vaccine is gaining attention for its potential anti-aging properties. Dylan Scott of Vox reported on February 5, 2026, that research indicates the vaccine may slow aging and reduce the risk of dementia. Scott noted that this "elixir for keeping our brains and bodies younger may already be sitting on pharmacy shelves across the United States."
Adding to the wellness discussion, Vox also explored the growing interest in mitochondria. Hannah Seo reported on February 5, 2026, that celebrities, tech entrepreneurs, and biohackers are increasingly focused on boosting mitochondrial function as a way to rejuvenate the body and extend lifespan. Seo described mitochondria as "the powerhouse of the cell," a concept familiar from middle-school biology.
Discussion
AI Experts & Community
Be the first to comment